CIK 0001528172 · Non-accelerated filer<br>Smaller reporting company
ENDONOVO THERAPEUTICS, INC.
Sign in to watch- Ticker
- ENDV
- Exchange
- OTC
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 452552528
- Phone
- (800) 489-4774
- Business address
- 6320 CANOGA AVENUE, 15TH FLOOR, WOODLAND HILLS, CA, 91367
- Former names
- Hanover Portfolio Acquisitions, Inc.
- 4 Open-market buy President bought 5,000 shares at $0.02 ($85)
- 4 Open-market buy CEO bought 36,000 shares at an average $0.02 ($632)
- 4 Open-market buy CEO bought 54,000 shares at an average $0.02 ($983)
- 4 Open-market buy President bought 22,000 shares at an average $0.02 ($414)
- 4 Open-market buy President bought 2,000 shares at $0.02 ($42)
- 4 Open-market buy CEO bought 43,000 shares at an average $0.02 ($827)
- 4 Open-market buy CEO bought 54,500 shares at an average $0.02 ($1,099)
- 4 Open-market buy CEO bought 21,000 shares at an average $0.02 ($413)
- 4 Open-market buy President bought 56,000 shares at an average $0.02 ($1,151)
- 4 Open-market buy CEO bought 103,500 shares at an average $0.02 ($2,040)
- 4 Open-market buy CEO bought 46,500 shares at an average $0.02 ($966)
- 4 Open-market buy CEO bought 40,000 shares at an average $0.02 ($889)
- 4 Open-market buy CEO bought 50,000 shares at an average $0.02 ($1,159)
- 4 Open-market buy CEO bought 17,000 shares at an average $0.02 ($389)
- 4 Open-market buy CEO bought 174,000 shares at an average $0.02 ($3,932)
- 4 Open-market buy CEO bought 17,500 shares at $0.02 ($390)
- 4 Open-market buy CEO bought 213,000 shares at an average $0.02 ($4,807)
- 4 Open-market buy CEO bought 38,000 shares at an average $0.03 ($985)
- 4 Open-market buy President bought 4,000 shares at $0.03 ($103)
- 4 Open-market buy CEO bought 46,000 shares at an average $0.03 ($1,188)
Page 3 of 16 · 306 filings